Shares of Inari Medical catapulted to a 12-month high Monday on a report medical devices maker Stryker is in advanced talks to buy it.

As of December 3, 2024, the average one-year price target for Inari Medical is $66.15/share. The forecasts range from a low of $50.50 to a high of $90.30. The average price target represents an ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per share.

(MENAFN- GlobeNewsWire - Nasdaq) Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan IRVINE, Calif.